Young-Hak Kim, MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  1. Application of AI and Robotics for Cardiovascular Care
  2. Utilization of CT-Based Myocardial Segmentation
  3. CT-Based Myocardial Segmentation: Novel Method and Clinical Implication
  4. CT-Based Functional Imaging
  5. Invited Case Presentation & Focus Review: Left Main
  6. Lessons from CROSS and PERFECT Randomized Studies
  7. What Is Different for LM vs. with Non-LM Bifurcations
  8. No, What the Matter Is Not the Stenting Technique
  9. Key Messages of CROSS and PERFECT Trials: Prognostic Factors and Mechanisms
  10. CT-Perfusion
  11. Perfusion CT: One Stop Shop for Structure and Perfusion
  12. Access Complication and Bleeding
  13. [Noninvasive Tests Before Cath: Simple & Better] CT Myocardial Perfusion Imaging: One-Stop Shop for Structure & Function
  14. [Debates: SYNTAX, Clinical SYNTAX, and SYNTAX 2... Is It Mandatory Before LM Revascularization?] No, I Do Not Have Time.
  15. CROSS and PERFECT Trials: Impact of Kissing Balloon (vs. No Kiss) and 2-Stent (vs. 1-stent) Technique for Bifurcations
  16. Outcomes of PCI vs. CABG: Current and Future
  17. Key Lessons from CROSS and PERFECT Trial
  18. CT-Perfusion
  19. Qualitative and Quantitative Angiographic Evaluation of Bifurcation Lesion
  20. Outcomes of Second-generation DES for LM
  21. Perfusion CT
  22. Taped Lives: Implantation of CoreValve, Transfemoral
  23. Still Unsolved Issue: Bifurcation Lesion
  24. Outcome Mapping: Techniques, Devices & Skills
  25. Meta-analysis: PCI vs. CABG for Unprotected LM Stenosis
  26. When Should We Consider TAVI Procedure in Korea (Interventionist's Viewpoint)?
  27. Current Status of CROSS and PERFECT Study
  28. Second-generation DES for LM: PRECOMBAT-2
  29. Ischemia-guided Revascularization for Stable Angina Patients
  30. Ischemia-guided Optimal Revascularization
  31. Angiographic Limitation in LM and Bifurcation Interpretation
  32. [Debate: Incomplete/Complete and Functional/Anatomical Revascularization] Incomplete Revascularization Is Enough.
  33. Inability of AV Cross
  34. The Use of Nobori in Bifurcation
  35. K Xience Registry Results
  36. Periprocedural Patient management
  37. Impact of Complete Revascularization Strategy
  38. How to Improve Outcomes: Prognostics Factors of Bifurcation Stenting
  39. Current Challenges in Left Main Disease
  40. Guidelines and Current Practice in the Management of ACS Patients
  41. Anatomical and Functional Approach for Bifurcation PCI: Lessons from CROSS and PERFECT Trial
  42. Responsibilities of Investigators in Clinical Trials: From Consent to Safety Reporting
  43. New Bifurcation Trials of CROSS and PERFECT Trial Based on Functional and Anatomical Evaluation
  44. Can High Risk of LM Revascularization Be Identified with Preoperational Clinical and Angiographic Characteristics?: LM-SCORE
  45. Fundamental and QCA Measurement
  46. Angiographic Features of Bifurcation Coronary Lesions
  47. Risk Stratification of Left Main Revascularization
  48. DES for Complex Left Main: Experience in Columbia University